Semaglutide 6-months therapy of type 2 diabetes mellitus restores adipose progenitors potential to develop metabolically active adipocytes
Autor: | Stafeev, I., Agareva, M., Michurina, S., Tomilova, A., Shestakova, E., Zubkova, E., Sineokaya, M., Ratner, E., Menshikov, M., Parfyonova, Ye, Shestakova, M. |
---|---|
Zdroj: | In European Journal of Pharmacology 5 May 2024 970 |
Databáze: | ScienceDirect |
Externí odkaz: |